Eva Berghausen

645 total citations
20 papers, 419 citations indexed

About

Eva Berghausen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Eva Berghausen has authored 20 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eva Berghausen's work include Pulmonary Hypertension Research and Treatments (14 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Eva Berghausen is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Eva Berghausen collaborates with scholars based in Germany, United States and Austria. Eva Berghausen's co-authors include Stephan Rosenkranz, Henrik ten Freyhaus, Marius Vantler, Evren Caglayan, Ralph T. Schermuly, Norbert Weißmann, Bhola K. Dahal, Stephan Baldus, Kai Kappert and Daniel Dumitrescu and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Eva Berghausen

18 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Berghausen Germany 11 277 156 127 57 50 20 419
A Gilbane United Kingdom 4 260 0.9× 196 1.3× 71 0.6× 49 0.9× 56 1.1× 4 494
Pin-I Chen United States 6 381 1.4× 245 1.6× 117 0.9× 109 1.9× 64 1.3× 6 545
Aleksandra Tretyn Germany 4 210 0.8× 116 0.7× 90 0.7× 40 0.7× 44 0.9× 5 361
Ewa Bieniek Poland 7 282 1.0× 119 0.8× 88 0.7× 57 1.0× 81 1.6× 13 421
Natalia Gambaryan France 9 469 1.7× 186 1.2× 113 0.9× 74 1.3× 98 2.0× 13 607
Zachary M. Augur United States 6 136 0.5× 136 0.9× 78 0.6× 85 1.5× 32 0.6× 7 362
Jennifer Bordenave France 8 263 0.9× 85 0.5× 91 0.7× 37 0.6× 41 0.8× 13 371
Tatiana V. Kudryashova United States 11 267 1.0× 218 1.4× 113 0.9× 76 1.3× 44 0.9× 20 484
Alice Bourgeois Canada 12 435 1.6× 307 2.0× 149 1.2× 133 2.3× 73 1.5× 19 625

Countries citing papers authored by Eva Berghausen

Since Specialization
Citations

This map shows the geographic impact of Eva Berghausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Berghausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Berghausen more than expected).

Fields of papers citing papers by Eva Berghausen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Berghausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Berghausen. The network helps show where Eva Berghausen may publish in the future.

Co-authorship network of co-authors of Eva Berghausen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Berghausen. A scholar is included among the top collaborators of Eva Berghausen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Berghausen. Eva Berghausen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berghausen, Eva, Felix S.R. Picard, Apostolos Polykratis, et al.. (2024). Hematopoietic PI3Kδ deficiency aggravates murine atherosclerosis through impairment of Tregs. JCI Insight. 9(22).
2.
Vantler, Marius, Eva Berghausen, Dickson W.L. Wong, et al.. (2024). PI 3-kinase/AKT/FOXO1 signaling in smooth muscle cells protects against abdominal aortic aneurysm. European Heart Journal. 45(Supplement_1). 1 indexed citations
3.
Joseph, Christine, Eva Berghausen, Bernhard H. Rauch, et al.. (2022). Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension. Cardiovascular Research. 118(16). 3225–3238. 7 indexed citations
4.
Berghausen, Eva, Wiebke Janssen, Marius Vantler, et al.. (2021). Disrupted PI3K subunit p110α signaling protects against pulmonary hypertension and reverses established disease in rodents. Journal of Clinical Investigation. 131(19). 16 indexed citations
5.
Vantler, Marius, Eva Berghausen, Martin Mollenhauer, et al.. (2021). PI 3-kinase isoform PI3Kalpha controls smooth muscle cell functionality and protects against aortic aneurysm formation. European Heart Journal. 42(Supplement_1). 1 indexed citations
6.
Berghausen, Eva, Marius Vantler, Ralph T. Schermuly, et al.. (2020). The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice. Basic Research in Cardiology. 115(6). 68–68. 12 indexed citations
7.
Berghausen, Eva, et al.. (2019). Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension. Herz. 44(2). 130–137. 16 indexed citations
8.
9.
Berghausen, Eva, et al.. (2019). P1938In vitro characterization of a novel PI 3-kinase inhibitor for growth factor-induced effects in pulmonary artery smooth muscle cells. European Heart Journal. 40(Supplement_1). 1 indexed citations
10.
Olschewski, Andrea, Eva Berghausen, Christina A. Eichstaedt, et al.. (2018). Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 4–10. 26 indexed citations
11.
Vantler, Marius, et al.. (2018). P3789SGC-stimulation via BAY 41-2272 exerts antiatherogenic effects in LDLR- and ApoE-deficient mice. European Heart Journal. 39(suppl_1). 1 indexed citations
12.
Vantler, Marius, et al.. (2016). Abstract 15760: Inhibition of PI3kα Overcomes Apoptosis Resistance of Smooth Muscle Cells in Pulmonary Hypertension and Thereby Reverses Established Vascular Remodeling. Circulation. 1 indexed citations
13.
Berghausen, Eva, Henrik ten Freyhaus, Ernst Wellnhofer, et al.. (2016). Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(4). 369–379. 39 indexed citations
14.
Vantler, Marius, Olli Leppänen, Maximilian Scherner, et al.. (2015). Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling. Arteriosclerosis Thrombosis and Vascular Biology. 35(6). 1434–1444. 11 indexed citations
15.
Freyhaus, Henrik ten, Eva Berghausen, Wiebke Janssen, et al.. (2015). Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 35(5). 1236–1245. 45 indexed citations
16.
Berghausen, Eva, Henrik ten Freyhaus, & Stephan Rosenkranz. (2013). Targeting of Platelet-Derived Growth Factor Signaling in Pulmonary Arterial Hypertension. Handbook of experimental pharmacology. 218. 381–408. 16 indexed citations
17.
Pullamsetti, Soni Savai, Eva Berghausen, Swati Dabral, et al.. (2012). Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 32(6). 1354–1365. 93 indexed citations
18.
Freyhaus, Henrik ten, Wiebke Janssen, Eva Berghausen, et al.. (2012). Abstract 19603: Disruption of βPDGF Receptor-Dependent PI3k and Plcγ Signaling Protects from Hypoxia-Induced Pulmonary Hypertension. Circulation. 126(suppl_21). 1 indexed citations
19.
Freyhaus, Henrik ten, Daniel Dumitrescu, Eva Berghausen, et al.. (2011). Imatinib mesylate for the treatment of pulmonary arterial hypertension. Expert Opinion on Investigational Drugs. 21(1). 119–134. 56 indexed citations
20.
Freyhaus, Henrik ten, Markus Dagnell, Marius Vantler, et al.. (2010). Hypoxia Enhances Platelet-derived Growth Factor Signaling in the Pulmonary Vasculature by Down-Regulation of Protein Tyrosine Phosphatases. American Journal of Respiratory and Critical Care Medicine. 183(8). 1092–1102. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Gilbane Breakdown of academic impact, for papers by Pin-I Chen Breakdown of academic impact, for papers by Aleksandra Tretyn Breakdown of academic impact, for papers by Ewa Bieniek Breakdown of academic impact, for papers by Natalia Gambaryan Breakdown of academic impact, for papers by Zachary M. Augur Breakdown of academic impact, for papers by Jennifer Bordenave Breakdown of academic impact, for papers by Tatiana V. Kudryashova Breakdown of academic impact, for papers by Alice Bourgeois
Rankless by CCL
2026